Toma HS - Search Results

1

Ocular HSV-1 latency, reactivation and recurrent disease.

Toma HS, Murina AT, Areaux RG Jr, Neumann DM, Bhattacharjee PS, Foster TP, Kaufman HE, Hill JM. Toma HS, et al. Semin Ophthalmol. 2008 Jul-Aug;23(4):249-73. doi: 10.1080/08820530802111085. Semin Ophthalmol. 2008. PMID: 18584563 Review.

2

Changes in ocular flora in eyes exposed to ophthalmic antibiotics.

Dave SB, Toma HS, Kim SJ. Dave SB, et al. Among authors: toma hs. Ophthalmology. 2013 May;120(5):937-41. doi: 10.1016/j.ophtha.2012.11.005. Epub 2013 Feb 13. Ophthalmology. 2013. PMID: 23415422 Clinical Trial.

3

Inhibition of choroidal neovascularization by intravitreal ketorolac.

Kim SJ, Toma HS. Kim SJ, et al. Among authors: toma hs. Arch Ophthalmol. 2010 May;128(5):596-600. doi: 10.1001/archophthalmol.2010.69. Arch Ophthalmol. 2010. PMID: 20457981

4

Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections.

Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ. Kim SJ, et al. Among authors: toma hs. Ophthalmology. 2010 Dec;117(12):2372-8. doi: 10.1016/j.ophtha.2010.03.034. Epub 2010 Jul 24. Ophthalmology. 2010. PMID: 20656351 Clinical Trial.

5

Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.

Kim SJ, Toma HS. Kim SJ, et al. Among authors: toma hs. Ophthalmology. 2011 Jul;118(7):1358-63. doi: 10.1016/j.ophtha.2010.12.014. Epub 2011 Mar 21. Ophthalmology. 2011. PMID: 21420176 Clinical Trial.

6

Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.

Dave SB, Toma HS, Kim SJ. Dave SB, et al. Among authors: toma hs. Ophthalmology. 2011 Oct;118(10):2035-40. doi: 10.1016/j.ophtha.2011.03.017. Ophthalmology. 2011. PMID: 21856006 Clinical Trial.

7

Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections.

Kim SJ, Toma HS. Kim SJ, et al. Among authors: toma hs. Arch Ophthalmol. 2011 Sep;129(9):1180-8. doi: 10.1001/archophthalmol.2011.213. Arch Ophthalmol. 2011. PMID: 21911665 Clinical Trial.

8

Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis.

Mehta S, Armstrong BK, Kim SJ, Toma H, West JN, Yin H, Lu P, Wayman LL, Recchia FM, Sternberg P Jr. Mehta S, et al. Retina. 2011 Jul-Aug;31(7):1316-22. doi: 10.1097/IAE.0b013e31820039af. Retina. 2011. PMID: 21358364

9

The safety, pharmacokinetics, and efficacy of intraocular celecoxib.

Kim SJ, Toma H, Shah R, Kompella UB, Vooturi SK, Sheng J. Kim SJ, et al. Invest Ophthalmol Vis Sci. 2014 Mar 10;55(3):1409-18. doi: 10.1167/iovs.13-13667. Invest Ophthalmol Vis Sci. 2014. PMID: 24458149 Free PMC article.

10

Improved assessment of laser-induced choroidal neovascularization.

Toma HS, Barnett JM, Penn JS, Kim SJ. Toma HS, et al. Microvasc Res. 2010 Dec;80(3):295-302. doi: 10.1016/j.mvr.2010.05.011. Epub 2010 Jun 8. Microvasc Res. 2010. PMID: 20553963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters